STOCK TITAN

Singular Genomics Systems, Inc. to Report Second Quarter 2022 Financial Results on August 9, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Singular Genomics Systems is set to release its Q2 2022 financial results on August 9, 2022, after market close. The management will host a conference call at 1:30 p.m. Pacific Time to discuss the results. Investors can access the live and archived webcast through the company's investor relations site.

Singular Genomics develops next-generation sequencing and multiomics technologies, with its G4 Sequencing Platform already on the market and another system, PX, in development.

Positive
  • None.
Negative
  • None.

SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the second quarter 2022 after the market close on Tuesday, August 9, 2022. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section.

About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine.

Investor Contact
Matt Clawson
949-370-8500
ir@singulargenomics.com

Media Contact
Dan Budwick, 1AB
973-271-6085
dan@1abmedia.com


FAQ

When will Singular Genomics report its Q2 2022 financial results?

Singular Genomics will report its Q2 2022 financial results on August 9, 2022, after market close.

What time is the conference call for Singular Genomics' financial results?

The conference call will begin at 1:30 p.m. Pacific Time on August 9, 2022.

How can I access the conference call by Singular Genomics?

You can access the conference call via a live and archived webcast at Singular Genomics' investor relations site.

What technologies does Singular Genomics focus on?

Singular Genomics focuses on next-generation sequencing and multiomics technologies.

Singular Genomics Systems, Inc.

NASDAQ:OMIC

OMIC Rankings

OMIC Latest News

OMIC Stock Data

50.69M
2.11M
13.9%
60.22%
2.85%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States of America
SAN DIEGO